NNI Articles: renal-business http://www.nephrologynews.com/rss/renal-business The latest articles from Nephrology News & Issues in the topic renal-business Liberty Dialysis enrolls 1,000th patient in peritoneal dialysis program The 1,000th PD patient was trained in two weeks by nephrology specialists to perform PD treatment independently, the company said in a statement. http://www.nephrologynews.com/renal-business/article/liberty-dialysis-enrolls-1000th-patient-in-peritoneal-dialysis-program 5/17/2012 11:26:00 AM CryoLife to acquire graft maker Hemosphere Tissue processing and medical device company CryoLife announced that it would acquire Hemosphere, the developer of the Hemodialysis Reliable Outflow (HeRO) Graft, for $17 million in cash, plus potential revenue milestone-based payments of up to $4.5 million. Hemosphere"s revenues were $5.3 million for the full year 2011. http://www.nephrologynews.com/renal-business/article/cryolife-to-acquire-graft-maker-hemoshpere 5/15/2012 12:02:00 PM American Renal reports Q1 revenue increase American Renal Associates Holdings Inc. and its subsidiary dialysis provider American Renal Holdings Inc. reported that revenues for the first quarter of 2012 increased almost 15% to $97.2 million, compared to $84.7 million in the same quarter last year. http://www.nephrologynews.com/renal-business/article/american-renal-reports-q1-revenue-increase 5/10/2012 2:59:00 PM American Renal Associates, Howard University Hospital begin dialysis clinic partnership Dialysis provider American Renal Associates LLC. and Howard University Hospital (HUH) have begun a partnership to jointly own and operate Howard University Dialysis LLC. located in the hospital. http://www.nephrologynews.com/renal-business/article/american-renal-associates-howard-university-hospital-begin-dialysis-clinic-partnership 5/8/2012 3:04:00 PM NxStage Q1 revenue increases 13% Dialysis product manufacturer NxStage Medical Inc. reported that total revenue for the first quarter increased 13% to $57 million, compared to $50.6 million in the first quarter of 2011. http://www.nephrologynews.com/renal-business/article/nxstage-q1-revenue-increases-13 5/8/2012 2:13:00 PM Rockwell reports Q1 sales down, continues heavy R&D investment Rockwell Medical reported that first quarter sales fell almost 10% to $12 million, compared to $13.3 in the same quarter last year. http://www.nephrologynews.com/renal-business/article/rockwell-reports-q1-sales-down-continues-heavy-r-and-d-investment 5/3/2012 12:11:00 PM Fresenius Q1 profit grows on acquisition gain Dialysis provider Fresenius Medical Care reported that its first quarter net profit grew 68% to $370 million, aided by $127 million from the acquisition of Liberty Dialysis Holdings Inc. Excluding the investment gain, net profit for the first quarter of 2012 grew 10% to $244 million. http://www.nephrologynews.com/renal-business/article/fresenius-q1-profit-grows-on-acquisition-gain 5/3/2012 11:40:00 AM DaVita Q1 profit up 48% Dialysis provider DaVita Inc. has reported a 48% increase in first-quarter profit compared to the same period last year. The company recorded first-quarter net income of $140.1 million, or $1.46 a share, compared with net income of $94.5 million, or 96 cents a share, in the first quarter of 2011. http://www.nephrologynews.com/renal-business/article/davita-q1-profit-up-48 5/2/2012 12:15:00 PM Nephros gets FDA approval for hemodiafiltration system to treat ESRD The U.S. Food and Drug Administration has granted Nephros Inc. 510(k) clearance for its hemodiafiltration system to treat end-stage renal disease. The device features the company"s OLpur MD220 Hemodiafilter and OLpur H2H Hemodiafiltration module. http://www.nephrologynews.com/renal-business/article/nephros-gets-fda-approval-for-hemodiafiltration-system-to-tread-esrd 5/1/2012 2:02:00 PM Amgen reports profit up in Q1, announces acquisition of Turkish pharmaceutical company Amgen Inc. reported that its first-quarter profit rose 5% on higher sales and beat analyst"s expectations. Revenue rose 9%, to $4.05 billion. http://www.nephrologynews.com/renal-business/article/amgen-profit-up-in-q1-announces-acquisition-of-turkish-pharmaceutical-company 4/25/2012 1:14:00 PM Amgen"s founding CEO dies Amgen announced that George Rathmann, founding CEO of Amgen from 1980 to 1988 and board chairman until 1990, has passed away. http://www.nephrologynews.com/renal-business/article/amgens-founding-ceo-dies 4/24/2012 2:43:00 PM Chicago-area family settles with Fresenius Medical Care over dialysis patient death The family of a dialysis patient who died after receiving treatment at a Fresenius Medical Care clinic in Berwyn, Ill. has settled with the dialysis company after filing suit, NBC Chicago reports. http://www.nephrologynews.com/renal-business/article/chicago-area-family-settles-with-fresenius-medical-care-over-dialysis-patient-death 4/19/2012 11:07:00 AM Rockwell Medical hires chief medical officer ockwell Medical has hired Raymond Pratt, MD, as chief medical officer. Pratt will oversee the clinical development and FDA regulatory process for Rockwell"s Soluble Ferric Pyrophosphate (SFP) and manage all aspects of clinical research and development for SFP and new drug indications. http://www.nephrologynews.com/renal-business/article/rockwell-medical-hires-chief-medical-officer 4/19/2012 10:16:00 AM CNA awards Fresenius Medical Care North America for employee safety Commercial insurance writer CNA has given dialysis provider Fresenius Medical Care North America with the CNA Safety in Excellence award for demonstrating significant improvements in OSHA injury rates for its U.S. operations. http://www.nephrologynews.com/renal-business/article/cna-awards-fresenius-medical-care-north-america-for-employee-safety 4/17/2012 11:37:00 AM DaVita CFO to leave for tea company Dialysis provider DaVita Inc. announced that Chief Financial Officer Luis Borgen will be leaving the company to become CFO of Boston-based Davids Tea Inc., a venture-capital backed company. http://www.nephrologynews.com/renal-business/article/davita-cfo-to-leave-for-tea-company 4/16/2012 11:18:00 AM Amgen to acquire KAI Pharmaceuticals Amgen Inc. announced that it would acquire KAI Pharmaceuticals, a privately held pharmaceutical company based in South San Francisco. KAI"s lead product candidate, KAI-4169, is initially studied for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease who are on dialysis. http://www.nephrologynews.com/renal-business/article/amgen-to-acquire-kai-pharmaceuticals 4/10/2012 10:27:00 AM Former DaVita nurse appeals conviction Kimberly Saenz, the former Davita dialysis nurse convicted of capital murder, appeared in court Wednesday to begin appealing her case, The Lufkin Daily News reports. http://www.nephrologynews.com/renal-business/article/former-davita-nurse-appeals-conviction 4/5/2012 10:24:00 AM DaVita acquires majority stake in Lehbi Care, Saudi Arabia Dialysis provider DaVita Inc. has acquired a controlling interest in Lehbi Care, a leading Riyadh, Saudi Arabia-based kidney care company. http://www.nephrologynews.com/renal-business/article/davita-acquires-majority-stake-in-lehbi-care-saudi-arabia 4/5/2012 8:42:00 AM Nationwide Laboratory Services gains new medical, environmental accreditation Dialysis specialty laboratory Nationwide Laboratory Services has been accredited by the American Association for Laboratory Accreditation for medical and environmental testing. http://www.nephrologynews.com/renal-business/article/nationwide-laboratory-services-gains-new-medical-environmental-accreditation 4/4/2012 4:27:00 PM Fresenius Medical Care signs licensing agreement in Europe for antipruritic drug Dialysis provider Fresenius Medical Care AG & Co. KGaA has signed an agreement with Toray Industries Inc for the exclusive development and marketing right in Europe of an injectable form of TRK-820, an investigative antipruritic agent originated and developed by Toray. http://www.nephrologynews.com/renal-business/article/fresenius-medical-care-signs-licensing-agreement-in-europe-for-antipruritic-drug 4/4/2012 3:31:00 PM